Uzbekistan Pharmaceuticals and Healthcare Report Q2 2016
BMI View: Non-communicable conditions will remain the leading contributors to Uzbekistan's burden of disease. Nevertheless, the country will be challenged in managing a tuberculosis epidemic and improving its relatively poor prognosis for infectious diseases control. Pharmaceutical companies with drug portfolios addressing both infectious diseases and chronic diseases will see commercial opportunities arise in Uzbekistan. However, we expect that this will be moderated by the low affordability of pharmaceuticals and the limited capacity of the Uzbek healthcare system to purchase medicines.
Headline Expenditure Projections
Pharmaceuticals: UZS2.78trn (USD956mn) in 2015 to UZS3.43trn (USD1.14bn) in 2016; 23.1% in local currency terms and 19.7% in US dollar terms. Forecast in US dollar terms revised upwards compared to the previous quarter.
Healthcare: UZS10.7trn (USD4.17bn) in 2015 to UZS12.8trn (USD4.27bn) in 2016; 19.2% in local currency terms and 2.2% in US dollar terms. Forecast in local currency terms revised upwards compared to the previous quarter.
- BMI Industry View
- Table: Headline Pharmaceuticals & Healthcare Forecasts (Uzbekistan 2014-2020)
- SWOT
- Industry Forecast
- Pharmaceutical Market Forecast
- Table: Pharmaceutical Sales, Historical Data And Forecasts (Uzbekistan 2012-2020)
- Healthcare Market Forecast
- Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2012-2020)
- Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2012-2020)
- Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2012-2020)
- Prescription Drug Market Forecast
- Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2012-2020)
- Patented Drug Market Forecast
- Table: Patented Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2012-2020)
- Generic Drug Market Forecast
- Table: Generic Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2012-2020)
- OTC Medicine Market Forecast
- Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Uzbekistan 2012-2020)
- Pharmaceutical Trade Forecast
- Table: Pharmaceutical Trade Data And Forecasts (Uzbekistan 2014-2020)
- Table: Pharmaceutical Trade Data And Forecasts local currency (Uzbekistan 2014-2020)
- Industry Risk/Reward Index
- Central And Eastern Europe Risk/Reward Index
- Uzbekistan Risk/Reward Index
- Rewards
- Risks
- Regulatory Review
- Counterfeit Drugs
- Intellectual Property Issues
- Pricing And Reimbursement
- Market Overview
- Healthcare Sector
- Healthcare Provision
- Health Insurance Sector
- Healthcare Sector Reforms
- Research And Development
- Clinical Trials
- International Cooperation
- Epidemiology
- Competitive Landscape
- Research-Based Industry
- Table: Multinational Market Activity
- Generic Drugmakers
- Leading Domestic Players
- Table: List Of Companies In Uzpharmsanoat SJSC (as of October 7 2013)
- Pharmaceutical Sector Reforms
- Foreign Pharmaceutical Industry
- Pharmaceutical Distribution
- Pharmaceutical Retail Sector
- Company Profile
- Asklepiy Pharmaceutical Company
- Jurabek Laboratories
- Uzpharmsanoat
- Demographic Forecast
- Table: Population Headline Indicators (Uzbekistan 1990-2025)
- Table: Key Population Ratios (Uzbekistan 1990-2025)
- Table: Urban/Rural Population & Life Expectancy (Uzbekistan 1990-2025)
- Table: Population By Age Group (Uzbekistan 1990-2025)
- Table: Population By Age Group % (Uzbekistan 1990-2025)
- Glossary
- Methodology
- Pharmaceutical Expenditure Forecast Model
- Healthcare Expenditure Forecast Model
- Notes On Methodology
- Risk/Reward Index Methodology
- Index Overview
- Table: Pharmaceutical Risk/Reward Index Indicators
- Indicator Weightings
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook